Certainly, oral administration of AM80 resulted in a decrease in α-SMA expression and an increase in Meflin expression in CAFs in a pancreatic cancer mouse model, suggesting that AM80 is capable of reprogramming pCAFs into rCAFs [15]. The gene discussed is ACTA1; the disease is familial pancreatic carcinoma.